(1)
Stanisic, S.; Bertolotto, A.; Berto, P.; Di Procolo, P.; Morawski, J. The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy. Grhta 2019, 6.